Diastolic Function Predicts Survival After Renal Revascularization

Ghanami, Racheed J.; Rana, Hamza; Craven, Tim; Corriere, Matthew A.; Moore, P. R.; Hoyle, John R.; Geary, Randolph L.; Edwards, Matthew S.; Godshall, Christopher J.; Hansen, Kimberley J.

doi:10.1016/j.jvs.2010.10.034

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results extend previous reports of more prevalent LV diastolic dysfunction in patients with RVHT. [13][14][15] However, most previous studies included a smaller number of patients and control subjects with renal dysfunction 14,16 and/or patients with RVHT undergoing renal artery revascularization. 13,23 Our study included a larger number of patients, most of who had SCr levels <2 mg/ dl.…”

Section: Discussionmentioning

confidence: 99%

Cardiac Function In Renovascular Hypertensive Patients With and Without Renal Dysfunction

Khangura

Eirin

Kane

et al. 2013

American Journal of Hypertension

View full text Add to dashboard Cite

Among hypertensive patients undergoing echocardiography, cardiac structure and diastolic function are impaired in RVHT patients compared with EHT patients and remain different after adjustment for multiple significant covariables. When associated with significant renal dysfunction, RVHT aggravates LV hypertrophy and both systolic and diastolic dysfunction. Hence, identification of RVHT and renal dysfunction warrants development of targeted management strategies.

show abstract

Section: Discussionmentioning

confidence: 99%

Cardiac Function In Renovascular Hypertensive Patients With and Without Renal Dysfunction

Khangura

Eirin

Kane

et al. 2013

American Journal of Hypertension

View full text Add to dashboard Cite

show abstract

“…The association between LV diastolic dysfunction and ARAS -related CKD persisted after adjusting for age, sex, baseline BP levels and kidney function, diabetes mellitus, smoking status, and the use of statins. 2,15 Also, Ghanami et al 22 found that diastolic dysfunction was frequent (61.8%) in the patients with ARAS who underwent revascularization, and was associated with increased mortality during follow -up.…”

Section: Atherosclerotic Renal Artery Stenosis Renal Revascularizatio...mentioning

confidence: 97%

Atherosclerotic renovascular disease and cardiovascular risk: new concepts

Januszewicz¹,

Januszewicz²,

Prejbisz³

et al. 2022

Polish Archives of Internal Medicine

View full text Add to dashboard Cite

Atherosclerotic renovascular disease and cardiovascular risk 1 other vascular beds. The prevalence of ARAS increases with age, particularly in the patients with a history of smoking, hypertension, diabetes, peripheral artery disease, or coronary artery disease (CAD). 6-8 ARAS is usually localized in the ostium and proximal third of the main renal artery, and sometimes the atherosclerotic plaque may extend into the renal artery. ARAS can affect one or both renal arteries, and at more advanced stages segmental and diffuse intrarenal atherosclerosis develops, predominantly in the patients with ischemic nephropathy. 1-3 ARAS can lead to the occurrence of resistant hypertension and can progressively impair the renal function. ARAS can cause serious cardiac complications, such as flash pulmonary edema or congestive heart failure (HF). [1][2][3] ARAS is a multifaceted disease due to the complex interplay between RAS, hypertension, and Introduction Renal vascular hypertension (RVHT) is one of the most common secondary forms of hypertension. It is estimated that 1% to 5% of all cases of hypertension can be attributed to this condition. The prevalence may reach up to 6.8% in the older population (>65 years). 1-3 RVHT is generally caused by progressive stenosis of the renal artery most often due to atherosclerosis, and less often due to fibromuscular dysplasia. 4 The remaining rare or very rare causes, that is, consequences of other stenotic lesions, vascular malformations, or thrombotic complications may also be responsible for development of RVHT. 5 Atherosclerotic renal artery stenosis (ARAS) accounts for approximately 90% to 95% percent of cases of renal artery stenosis (RAS) and is predominantly seen in the populations with other cardiovascular risk factors or atherosclerotic lesions in

show abstract

Diastolic Function Predicts Survival After Renal Revascularization

Cited by 2 publications

References 0 publications

Cardiac Function In Renovascular Hypertensive Patients With and Without Renal Dysfunction

Cardiac Function In Renovascular Hypertensive Patients With and Without Renal Dysfunction

Atherosclerotic renovascular disease and cardiovascular risk: new concepts

Contact Info

Product

Resources

About